TURNOVER (x1000 NOK)
NET PROFIT (x1000 NOK)
Pharmapress Oy
Closing information (x1000 NOK)
Closing information | 2017/12 | 2016/12 | 2015/12 |
Turnover |
10,824
|
11,113
|
13,182 |
Financial expenses | 0 | ||
Earnings before taxes |
669
|
472
|
660 |
Total assets |
6,406
|
5,788
|
6,127 |
Current assets |
3,631
|
4,679
|
4,741 |
Current liabilities |
1,210
|
1,027
|
1,023 |
Equity capital |
5,186
|
4,761
|
5,095 |
- share capital |
295
|
273
|
287 |
Financial ratios
Fiscal year | 2017/12 | 2016/12 | 2015/12 |
Solvency |
81.0%
|
82.3%
|
83.2% |
Turnover per employee | |||
Profit as a percentage of turnover |
6.2%
|
4.2%
|
5.0% |
Return on assets (ROA) | 10.8% | ||
Current ratio |
300.1%
|
455.6%
|
463.4% |
Return on equity (ROE) |
12.9%
|
9.9%
|
13.0% |
Change turnover |
-1,210
|
-1,417
|
-1,023 |
Change turnover % |
-10%
|
-11%
|
-7% |
Chg. No. of employees | |||
Chg. No. of employees % |
Total value of public sale
Fiscal year | 2017/12 | 2016/12 | 2015/12 |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.